Staphylococcus aureus
Microbiology · Bacteriology · lean revision notes
Staphylococcus aureus
Staphylococcus aureus is the single most clinically important and most-tested gram-positive coccus in NEET PG. Its examinable footprint spans virulence factors, toxin-mediated syndromes, suppurative infections, lab diagnosis, and the ever-popular MRSA. Master this organism and you cover a disproportionate slice of the Microbiology paper.
Classification & basic characteristics
Staphylococcus species are gram-positive cocci arranged in grape-like clusters (Greek staphyle = bunch of grapes). They are non-motile, non-sporing, catalase-positive, and facultatively anaerobic. The genus is separated from Streptococcus by the catalase test (Staph positive, Strep negative).
Within the genus, S. aureus is distinguished from the coagulase-negative staphylococci (CoNS) such as S. epidermidis and S. saprophyticus by the coagulase test.
| Feature | S. aureus | S. epidermidis | S. saprophyticus |
|---|---|---|---|
| Coagulase | Positive | Negative | Negative |
| Colony pigment | Golden-yellow | White | White |
| Mannitol fermentation | Yes (yellow on MSA) | No | Variable |
| Novobiocin | Sensitive | Sensitive | Resistant |
| DNase | Positive | Negative | Negative |
| Classic disease | Abscess, TSS, SSSS, food poisoning | Prosthetic device/IV-line infection, endocarditis on prosthetic valves | UTI in sexually active young women |
High-yield: Novobiocin resistance separates S. saprophyticus (resistant) from S. epidermidis (sensitive). Coagulase separates S. aureus (positive) from all CoNS (negative).
S. aureus grows on ordinary media producing golden-yellow colonies (carotenoid pigment staphyloxanthin, itself an antioxidant virulence factor). On mannitol salt agar (MSA) — a selective and differential medium with 7.5% NaCl and phenol red — S. aureus ferments mannitol turning the medium yellow. On blood agar it produces beta-haemolysis.
Virulence factors
The breadth of S. aureus disease reflects an arsenal of cell-wall components, enzymes, and toxins. Examiners love linking a factor to its specific function.
Cell-surface / structural factors
- Protein A — binds the Fc region of IgG, blocking opsonisation and complement-mediated phagocytosis. Used in coagglutination tests in the lab. A signature antiphagocytic factor.
- Capsular polysaccharide and slime/biofilm — antiphagocytic; biofilm is especially relevant for CoNS on prosthetic devices.
- Teichoic acid / clumping factor (bound coagulase) — mediates adherence; clumping factor causes slide-coagulase positivity.
- Staphyloxanthin — golden pigment that quenches reactive oxygen species inside neutrophils.
Enzymes
- Coagulase — converts fibrinogen to fibrin, walling off the organism (abscess formation). The defining enzyme of S. aureus. Two forms: bound (clumping factor, slide test) and free (tube test).
- Catalase — breaks down H₂O₂; distinguishes Staph from Strep.
- Hyaluronidase ("spreading factor"), staphylokinase (fibrinolysin), lipase, DNase, β-lactamase (penicillinase).
Toxins
| Toxin | Action | Disease |
|---|---|---|
| Alpha (α) haemolysin | Pore-forming, lyses RBCs, platelets, dermonecrosis | Tissue necrosis |
| Panton-Valentine leukocidin (PVL) | Lyses leukocytes; forms pores | Necrotising pneumonia, recurrent furuncles (CA-MRSA marker) |
| Exfoliatin (exfoliative toxin A/B) | Serine protease, cleaves desmoglein-1 in desmosomes | SSSS, bullous impetigo |
| TSST-1 | Superantigen → massive non-specific T-cell activation, cytokine storm | Toxic shock syndrome |
| Enterotoxins (A–E; A most common) | Superantigen, heat-stable (preformed) | Food poisoning |
High-yield: Both TSST-1 and enterotoxins are superantigens — they bridge MHC class II to the TCR Vβ region outside the antigen groove, activating up to 20% of T cells and triggering a massive cytokine (IL-1, IL-2, TNF) release.
High-yield: Staphylococcal enterotoxin is heat-stable (preformed) — reheating contaminated food does NOT prevent food poisoning. This is the basis of the short (1–6 h) incubation period.
Mnemonic for superantigen toxins: "TSST and enterotoxins TURN ON Too many T-cells."
Pathogenesis & clinical spectrum
S. aureus disease falls into two mechanistic buckets: (1) pyogenic/invasive (organism-driven) and (2) toxin-mediated (toxin-driven, often no organism at the site).
Invasive (pyogenic) infections → abscess-forming:
- Skin & soft tissue: folliculitis, furuncle (boil), carbuncle, abscess, cellulitis, wound infection, mastitis (breast abscess in lactating women), surgical-site infection.
- Deep: osteomyelitis (most common cause overall, including in sickle cell — although Salmonella is classically over-represented in sickle cell), septic arthritis (commonest cause of acute septic arthritis in adults and children >5 yrs), pyomyositis (tropical), psoas abscess.
- Endocarditis: the commonest cause of acute infective endocarditis and the leading cause in IV drug users (right-sided, tricuspid valve).
- Pneumonia: post-influenza secondary pneumonia, necrotising pneumonia (PVL), ventilator-associated.
- Bacteraemia/sepsis, metastatic abscesses.
- Device-related: IV catheter, prosthetic joint (more CoNS, but S. aureus too).
Toxin-mediated diseases:
- Staphylococcal food poisoning — preformed enterotoxin. Shortest incubation among bacterial food poisonings (1–6 h, classically 2–4 h), prominent vomiting, self-limiting (<24 h). Sources: custards, cream pastries, ham, processed meats, dairy.
- Toxic shock syndrome (TSS) — TSST-1. Classically menstruating women using high-absorbency tampons; also non-menstrual (surgical packing, wounds). Fever, hypotension, diffuse macular erythroderma → desquamation of palms and soles, multi-organ involvement.
- Staphylococcal scalded skin syndrome (SSSS, Ritter disease) — exfoliatin cleaving desmoglein-1. Affects neonates and young children (immature renal toxin clearance, lack of antibody). Widespread superficial epidermal splitting at granular layer, positive Nikolsky sign, but mucosa spared.
Clinical reasoning flow — toxin-mediated rash
Fever + diffuse rash + hypotension + recent tampon use → TSST-1 → Toxic shock syndrome → fluids + remove tampon + anti-staphylococcal antibiotic (clindamycin to suppress toxin + vancomycin/cloxacillin).
Neonate + flaccid bullae + positive Nikolsky + spared mucosa → exfoliatin → SSSS → IV anti-staphylococcal antibiotic + supportive skin care.
High-yield: SSSS vs TEN — both have a positive Nikolsky sign. SSSS splits at the granular layer (intraepidermal, superficial), spares mucosa, occurs in children, low mortality. Toxic epidermal necrolysis (TEN) splits at the dermo-epidermal junction (full-thickness), involves mucosa, drug-induced, high mortality. Frozen-section / biopsy of the blister roof is the fastest distinguisher.
Diagnosis & investigations
Specimen: pus (abscess), blood (bacteraemia/endocarditis), sputum, CSF, food/vomitus (food poisoning).
Microscopy: Gram stain shows gram-positive cocci in clusters.
Culture: Blood agar (golden β-haemolytic colonies), MSA (selective — yellow colonies).
Key biochemical tests — stepwise lab identification:
- Catalase test → positive → genus Staphylococcus (vs Strep).
- Coagulase test → positive → S. aureus.
- Slide test: detects bound coagulase (clumping factor) — rapid, screening; can give false negatives (confirm with tube test).
- Tube test: detects free coagulase — converts fibrinogen→fibrin clot; the gold standard/confirmatory test.
- If coagulase negative → CoNS → use novobiocin to separate S. saprophyticus (resistant) from S. epidermidis (sensitive).
Supportive: DNase test positive, mannitol fermentation positive, Voges-Proskauer positive, latex agglutination (protein A + clumping factor).
High-yield: The tube coagulase test (free coagulase) is the confirmatory test for S. aureus. Slide test detects bound coagulase (clumping factor).
High-yield: Phage typing was historically used for epidemiological tracing of S. aureus outbreaks; now largely replaced by molecular methods (PFGE, MLST, spa typing).
MRSA & antimicrobial resistance
This is among the highest-yield single concepts for the exam.
- Resistance mechanism: the mecA gene (on the SCCmec mobile element) encodes an altered penicillin-binding protein, PBP2a, which has low affinity for β-lactams → resistance to all β-lactams (including methicillin, oxacillin, cloxacillin, and all cephalosporins except the newer anti-MRSA cephalosporins like ceftaroline).
- Detected in the lab using a cefoxitin disc (better inducer of mecA than oxacillin) or by detecting mecA / PBP2a.
| Type | Setting | Genetics | Typical resistance |
|---|---|---|---|
| HA-MRSA (hospital) | Nosocomial, devices, prior antibiotics | Larger SCCmec (II/III) | Multidrug-resistant |
| CA-MRSA (community) | Healthy young, skin infections | Smaller SCCmec IV, often PVL+ | Fewer drugs; skin/necrotising pneumonia |
β-lactamase (penicillinase) producers (>90% of isolates) are resistant to penicillin G → treat with penicillinase-stable penicillins (cloxacillin/dicloxacillin/flucloxacillin) if MSSA.
High-yield: mecA → PBP2a → resistance to all β-lactams. Screen with the cefoxitin disc. Confirm by detecting mecA gene.
VISA / VRSA: intermediate or full vancomycin resistance. VISA arises from a thickened cell wall trapping vancomycin; VRSA acquires the vanA gene from Enterococcus (alters peptidoglycan terminus D-Ala-D-Ala → D-Ala-D-Lac).
Treatment / drug of choice
| Scenario | Drug of choice |
|---|---|
| MSSA (methicillin-sensitive) | Anti-staphylococcal penicillin — cloxacillin / flucloxacillin / nafcillin (or cefazolin) |
| MRSA – serious/systemic | Vancomycin (linezolid, daptomycin, teicoplanin as alternatives) |
| MRSA – skin/soft tissue (mild) | Clindamycin, co-trimoxazole, doxycycline, linezolid |
| Toxin-mediated (TSS) | Add clindamycin (suppresses toxin synthesis by inhibiting protein synthesis) + vancomycin/cloxacillin |
| MRSA pneumonia / VRSA | Linezolid; daptomycin NOT for pneumonia (inactivated by surfactant) |
| Nasal carriage decolonisation | Mupirocin intranasal + chlorhexidine wash |
High-yield: Daptomycin is inactivated by pulmonary surfactant — never use it for pneumonia. Use linezolid or vancomycin instead.
High-yield: In toxin-mediated disease (TSS/SSSS/necrotising), add clindamycin as an adjunct because it switches off toxin production (protein-synthesis inhibitor), unlike β-lactams which can transiently increase toxin release.
Carrier state: The anterior nares are the principal reservoir; ~20–30% of people are persistent carriers. Carriage is a major source of surgical-site infection and outbreaks. Decolonise high-risk surgical patients with mupirocin.
Complications
- Sepsis & septic shock, metastatic abscesses (brain, kidney, spleen).
- Infective endocarditis with valve destruction and embolic phenomena.
- Acute renal failure / multi-organ failure in TSS.
- Fluid/electrolyte loss and secondary infection in extensive SSSS.
- Chronic osteomyelitis with sequestrum and sinus formation.
- Recurrent furunculosis with PVL strains.
Key differentials
- Staphylococcus vs Streptococcus: catalase (Staph +, Strep −), arrangement (clusters vs chains).
- SSSS vs TEN vs bullous impetigo: plane of cleavage, mucosal involvement, age, Nikolsky (see table above).
- TSS (staphylococcal) vs streptococcal TSS: Strep TSS has a definite portal/soft-tissue infection (necrotising fasciitis), positive blood cultures, and worse mortality; Staph TSS often has negative blood cultures and a desquamating rash.
- Staph food poisoning vs Bacillus cereus (emetic) vs Clostridium perfringens: Staph and B. cereus emetic type have short incubation (1–6 h) with vomiting (both preformed/heat-stable toxin); C. perfringens causes watery diarrhoea at 8–16 h.
- MSSA vs MRSA: cefoxitin disc / mecA.
| Food poisoning | Incubation | Predominant symptom | Toxin |
|---|---|---|---|
| S. aureus | 1–6 h | Vomiting | Preformed enterotoxin (heat-stable) |
| B. cereus (emetic) | 1–6 h | Vomiting | Cereulide (heat-stable, fried rice) |
| C. perfringens | 8–16 h | Watery diarrhoea | Enterotoxin (in gut) |
| Vibrio/ETEC | 12–72 h | Watery diarrhoea | Enterotoxin |
Recently asked / exam angle
- Coagulase test interpretation — which form (free vs bound) each method detects; tube test = confirmatory.
- Superantigen mechanism — image/diagram of MHC II–TCR Vβ cross-linking; "which toxin is a superantigen?" (TSST-1 and enterotoxins).
- Exfoliatin target = desmoglein-1 — frequently paired with pemphigus foliaceus (same target) as an integrative question.
- MRSA mechanism (mecA/PBP2a) and cefoxitin disc screening.
- Daptomycin contraindicated in pneumonia (surfactant inactivation) — a classic single-best-answer.
- Novobiocin sensitivity to identify S. saprophyticus in a young woman with UTI.
- Clindamycin as anti-toxin adjunct in TSS/SSSS.
- Shortest incubation period among food poisonings → S. aureus.
- IV drug user + tricuspid endocarditis → S. aureus.
- VISA = thick cell wall; VRSA = vanA from Enterococcus.
Rapid revision
- Gram-positive cocci in clusters, catalase positive → Staphylococcus.
- Coagulase positive → S. aureus; tube test (free coagulase) is confirmatory.
- Golden colonies (staphyloxanthin), mannitol-fermenting (yellow on MSA), DNase positive.
- Protein A binds Fc of IgG → antiphagocytic.
- Exfoliatin cleaves desmoglein-1 → SSSS (children, mucosa spared, splits at granular layer).
- TSST-1 and enterotoxins are superantigens (MHC II–TCR Vβ).
- Enterotoxin is heat-stable & preformed → food poisoning, incubation 1–6 h, vomiting predominant.
- PVL → necrotising pneumonia and recurrent furuncles; marker of CA-MRSA.
- S. aureus = commonest cause of acute osteomyelitis, septic arthritis, acute endocarditis, and IVDU (tricuspid) endocarditis.
- MRSA = mecA → PBP2a, resists all β-lactams; screen with cefoxitin disc.
- MSSA → cloxacillin; MRSA systemic → vancomycin; add clindamycin to suppress toxin.
- Daptomycin never for pneumonia (surfactant); VISA = thick wall, VRSA = vanA from Enterococcus; nasal carriage → mupirocin decolonisation.